1. Home
  2. INSP vs IRON Comparison

INSP vs IRON Comparison

Compare INSP & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$56.42

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$68.62

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSP
IRON
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
INSP
IRON
Price
$56.42
$68.62
Analyst Decision
Buy
Strong Buy
Analyst Count
16
11
Target Price
$94.00
$103.18
AVG Volume (30 Days)
894.4K
297.9K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
179.43
N/A
EPS
4.89
N/A
Revenue
$82,050,000.00
N/A
Revenue This Year
$8.02
N/A
Revenue Next Year
$8.11
$283.52
P/E Ratio
$11.46
N/A
Revenue Growth
62.18
N/A
52 Week Low
$48.30
$40.00
52 Week High
$163.35
$99.50

Technical Indicators

Market Signals
Indicator
INSP
IRON
Relative Strength Index (RSI) 51.49 54.96
Support Level $53.11 $57.79
Resistance Level $60.15 $69.36
Average True Range (ATR) 3.19 2.55
MACD 0.52 0.13
Stochastic Oscillator 69.66 54.65

Price Performance

Historical Comparison
INSP
IRON

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: